Relmada Therapeutics Inc (NASDAQ:RLMD)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - RLMD

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - RLMD

  • Market Cap$523.030m
  • SymbolNASDAQ:RLMD
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS75955J4022

Company Profile

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.Relmada Therapeutics Inc is engaged in developing chemical entities with novel versions of proven drug products that address areas of high unmet medical need in the treatment of central nervous system diseases.

Latest RLMD news

Currently there for this company. Visit our news hub for other news .